Terence M. Williams, Ph.D. - Publications

Affiliations: 
2004 Yeshiva University, New York, NY, United States 
Area:
Cell Biology, Molecular Biology, Oncology

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Salamekh S, Rong Y, Ayan AS, Mo X, Williams TM, Mayr NA, Grecula JC, Chakravarti A, Xu-Welliver M. Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables. Plos One. 11: e0153245. PMID 27049962 DOI: 10.1371/Journal.Pone.0153245  0.68
2015 Chablani P, Nguyen P, Pan X, Robinson A, Walston S, Wu C, Frankel WL, Chen W, Bekaii-Saab T, Chakravarti A, Wuthrick E, Williams TM. Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery. American Journal of Clinical Oncology. PMID 26703815 DOI: 10.1097/Coc.0000000000000214  0.68
2015 Ahn DH, Williams TM, Goldstein DA, El-Rayes B, Bekaii-Saab T. Adjuvant therapy for pancreas cancer in an era of value based cancer care. Cancer Treatment Reviews. PMID 26620819 DOI: 10.1016/J.Ctrv.2015.11.004  0.68
2015 Nguyen P, Wuthrick E, Chablani P, Robinson A, Simmons L, Wu C, Arnold M, Harzman AE, Husain S, Schmidt C, Abdel-Misih S, Bekaii-Saab T, Chakravarti A, Williams TM. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience. American Journal of Clinical Oncology. PMID 26535992 DOI: 10.1097/Coc.0000000000000248  0.68
2015 Ben-Josef E, George A, Regine W, Abrams RA, Morgan MA, Thomas DG, Schaefer P, DiPetrillo T, Fromm M, Small W, Narayan S, Winter K, Griffith KA, Guha C, Williams TM. Glycogen Synthase Kinase 3β predicts survival in adenocarcinoma of the pancreas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26240274 DOI: 10.1158/1078-0432.Ccr-15-0789  0.68
2015 Rong Y, Bazan JG, Sekhon A, Haglund K, Xu-Welliver M, Williams T. Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers. Plos One. 10: e0131945. PMID 26158847 DOI: 10.1371/Journal.Pone.0131945  0.68
2015 Chatterjee M, Ben-Josef E, Thomas DG, Morgan MA, Zalupski MM, Khan G, Andrew Robinson C, Griffith KA, Chen CS, Ludwig T, Bekaii-Saab T, Chakravarti A, Williams TM. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Scientific Reports. 5: 10867. PMID 26065715 DOI: 10.1038/Srep10867  0.68
2015 Houghton PJ, Kurmasheva RT, Kolb EA, Gorlick R, Maris JM, Wu J, Tong Z, Arnold MA, Chatterjee M, Williams TM, Smith MA. Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP). Pediatric Blood & Cancer. 62: 1214-21. PMID 25809532 DOI: 10.1002/Pbc.25474  0.68
2015 Walston S, Hamstra DA, Oh K, Woods G, Guiou M, Olshefski RS, Chakravarti A, Williams TM. A multi-institutional experience in pediatric high-grade glioma. Frontiers in Oncology. 5: 28. PMID 25741472 DOI: 10.3389/Fonc.2015.00028  0.68
2013 Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, et al. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer. 119: 2692-700. PMID 23720019 DOI: 10.1002/Cncr.28117  0.68
2013 Williams TM, Maier A. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies. Cancer Journal (Sudbury, Mass.). 19: 272-81. PMID 23708074 DOI: 10.1097/Ppo.0B013E31829452A5  0.68
2013 Williams TM, Galbán S, Li F, Heist KA, Galbán CJ, Lawrence TS, Holland EC, Thomae TL, Chenevert TL, Rehemtulla A, Ross BD. DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases. Translational Oncology. 6: 133-42. PMID 23544166 DOI: 10.1593/Tlo.13214  0.68
2012 Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD, Leopold JS, Chenevert TL, Lawrence TS, Rehemtulla A, Mikkelsen T, Holland EC, Galbán CJ, Ross BD. DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. Plos One. 7: e35857. PMID 22536446 DOI: 10.1371/Journal.Pone.0035857  0.68
2012 Williams TM, Flecha AR, Keller P, Ram A, Karnak D, Galbán S, Galbán CJ, Ross BD, Lawrence TS, Rehemtulla A, Sebolt-Leopold J. Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Molecular Cancer Therapeutics. 11: 1193-202. PMID 22411900 DOI: 10.1158/1535-7163.Mct-12-0098  0.68
2012 Williams TM, Moran JM, Hsu SH, Marsh R, Yanke B, Fraass BA, Pierce LJ. Contralateral breast dose after whole-breast irradiation: an analysis by treatment technique. International Journal of Radiation Oncology, Biology, Physics. 82: 2079-85. PMID 21489713 DOI: 10.1016/J.Ijrobp.2011.01.049  0.68
2011 Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG. Role of cholesterol in the development and progression of breast cancer. The American Journal of Pathology. 178: 402-12. PMID 21224077 DOI: 10.1016/J.Ajpath.2010.11.005  0.68
2011 Yao H, Zeng ZZ, Fay KS, Veine DM, Staszewski ED, Morgan M, Wilder-Romans K, Williams TM, Spalding AC, Ben-Josef E, Livant DL. Role of α5β1 integrin up-regulation in radiation-induced invasion by human pancreatic cancer cells Translational Oncology. 4: 282-292. DOI: 10.1593/tlo.11133  0.68
2008 Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, Demichelis F, Solomon KR, Loda M, Rubin MA, Lisanti MP, Freeman MR. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle (Georgetown, Tex.). 7: 2257-67. PMID 18635971 DOI: 10.4161/Cc.7.14.6475  0.68
2007 Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biology & Therapy. 6: 1263-8. PMID 17786030 DOI: 10.4161/Cbt.6.8.4447  0.68
2007 Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Research. 67: 3106-16. PMID 17409417 DOI: 10.1158/0008-5472.Can-06-3401  0.68
2006 Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. The American Journal of Pathology. 169: 1784-801. PMID 17071600 DOI: 10.2353/Ajpath.2006.060590  0.68
2006 Medina FA, de Almeida CJ, Dew E, Li J, Bonuccelli G, Williams TM, Cohen AW, Pestell RG, Frank PG, Tanowitz HB, Lisanti MP. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infection and Immunity. 74: 6665-74. PMID 16982844 DOI: 10.1128/Iai.00949-06  0.68
2006 Medina FA, Williams TM, Sotgia F, Tanowitz HB, Lisanti MP. A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle (Georgetown, Tex.). 5: 1865-71. PMID 16929183 DOI: 10.4161/Cc.5.16.3132  0.68
2006 Hassan GS, Williams TM, Frank PG, Lisanti MP. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2393-401. PMID 16415072 DOI: 10.1152/Ajpheart.01161.2005  0.68
2006 Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, Lisanti MP. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. The American Journal of Pathology. 168: 292-309. PMID 16400031 DOI: 10.2353/Ajpath.2006.050429  0.68
2005 Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, Frank PG, Sotgia F, Lisanti MP. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle (Georgetown, Tex.). 4: 1817-25. PMID 16294037 DOI: 10.4161/Cc.4.12.2199  0.68
2005 Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Cell Cycle (Georgetown, Tex.). 4: 1808-16. PMID 16294019 DOI: 10.4161/Cc.4.12.2198  0.68
2005 Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MP. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. The Journal of Biological Chemistry. 280: 25134-45. PMID 15802273 DOI: 10.1074/Jbc.M501186200  0.68
2005 Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology. Cell Physiology. 288: C494-506. PMID 15692148 DOI: 10.1152/Ajpcell.00458.2004  0.68
2005 Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. American Journal of Physiology. Cell Physiology. 288: C1317-31. PMID 15689413 DOI: 10.1152/Ajpcell.00489.2004  0.68
2005 Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB, Scherer PE, Hotchkiss KA, Terman BI, Rollman B, Alileche A, Brojatsch J, Lisanti MP. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. American Journal of Physiology. Cell Physiology. 288: C1402-10. PMID 15689409 DOI: 10.1152/Ajpcell.00582.2004  0.68
2004 Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Annals of Medicine. 36: 584-95. PMID 15768830 DOI: 10.1080/07853890410018899  0.68
2004 Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. The Journal of Biological Chemistry. 279: 51630-46. PMID 15355971 DOI: 10.1074/Jbc.M409214200  0.68
2004 Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 53: 1261-70. PMID 15111495 DOI: 10.2337/Diabetes.53.5.1261  0.68
2004 Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia. The Journal of Biological Chemistry. 279: 24745-56. PMID 15044451 DOI: 10.1074/Jbc.M402064200  0.68
2004 Williams TM, Lisanti MP. The caveolin proteins. Genome Biology. 5: 214. PMID 15003112 DOI: 10.1186/Gb-2004-5-3-214  0.68
2003 Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry. 42: 15124-31. PMID 14690422 DOI: 10.1021/Bi0356348  0.68
2003 Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. The American Journal of Pathology. 162: 2059-68. PMID 12759260 DOI: 10.1016/S0002-9440(10)64337-4  0.68
2003 Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, Lisanti MP. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. The American Journal of Pathology. 162: 2029-39. PMID 12759258 DOI: 10.1016/S0002-9440(10)64335-0  0.68
2003 Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology. Cell Physiology. 285: C222-35. PMID 12660144 DOI: 10.1152/Ajpcell.00006.2003  0.68
2003 Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG, Lisanti MP. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Molecular Biology of the Cell. 14: 1027-42. PMID 12631721 DOI: 10.1091/Mbc.E02-08-0503  0.68
2003 Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. American Journal of Physiology. Cell Physiology. 284: C457-74. PMID 12388077 DOI: 10.1152/Ajpcell.00380.2002  0.68
2000 Megonigal MD, Cheung NK, Rappaport EF, Nowell PC, Wilson RB, Jones DH, Addya K, Leonard DG, Kushner BH, Williams TM, Lange BJ, Felix CA. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 97: 2814-9. PMID 10706619 DOI: 10.1073/Pnas.050397097  0.68
1999 Felix CA, Hosler MR, Slater DJ, Megonigal MD, Lovett BD, Williams TM, Nowell PC, Spinner NB, Owens NL, Hoxie J, Croce CM, Lange BJ, Rappaport EF. Duplicated regions of AF-4 intron 4 at t(4;11) translocation breakpoints. Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology. 4: 269-83. PMID 10671636 DOI: 10.1016/S1084-8592(99)80002-2  0.68
1998 Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, Lovett BD, Nowell PC, Blair IA, Rebbeck TR. Association of CYP3A4 genotype with treatment-related leukemia. Proceedings of the National Academy of Sciences of the United States of America. 95: 13176-81. PMID 9789061 DOI: 10.1073/Pnas.95.22.13176  0.68
1998 Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML, Felix CA. t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proceedings of the National Academy of Sciences of the United States of America. 95: 6413-8. PMID 9600980 DOI: 10.1073/Pnas.95.11.6413  0.68
Show low-probability matches.